This content is machine translated Multiple Sclerosis - 20th State of the Art Symposium, Lucerne App and video game-based training in MS therapy. Multiple sclerosis is a chronic inflammatory, degenerative autoimmune disease that can lead to significant impairments for those affected in their daily lives. App-based training offers and developments in the field…
View Post 7 min This content is machine translated Coxarthrosis “Common is common” In old age, complaints of the hip are a frequent reason for presentation to the family doctor. The earlier the correct diagnosis is made, the greater the treatment options. However,…
View Post 5 min This content is machine translated 21st Annual Meeting of the Swiss Stroke Society, Lausanne Primary CNS vasculitis – treat with or without immunosuppressants? On January 11, 2018, the 21st Annual Meeting of the Swiss Brain Stroke Society was held in Lausanne. An important topic was vasculitides, which, if they affect the CNS, can…
View Post 7 min This content is machine translated ECTRIMS/ACTRIMS in Paris MS in children – Does the same apply to therapy as in adults? At the ECTRIMS/ACTRIMS Congress, for once the pediatric population came into focus. Fingolimod was shown to be effective here as well. But the benefits don’t come “free.”
View Post 6 min This content is machine translated Psoriatic arthritis Current therapy options The heterogeneity of psoriatic arthritis (PsA) suggests a high number of undiagnosed manifestations. Guidance is provided by the CASPAR classification criteria. Therapy concepts should be multimodal – supported by a…
View Post 6 min This content is machine translated Rheumatoid arthritis Therapy overview 2017 – and what’s next? Prof. Paul Hasler, MD, Chief of Rheumatology, Kantonsspital Aarau, discussed the new approval of baricitinib in the indication of moderate to severe active RA with HAUSARZT PRAXIS. Where does the…
View Post 6 min This content is machine translated RCT, "real world data" or meta-analyses What counts in the treatment of multiple sclerosis? Randomized controlled trials remain the pivotal gold standard in the field of MS therapy studies. “Real-world observational data from large cohorts or registries can, however, provide valuable supplements for many…
View Post 5 min This content is machine translated Green-lipped mussel extracts for the treatment of joint complaints A dietary supplement from New Zealand prevails Oral or topical preparations from the New Zealand blue mussel, Perna canaliculus, German Grünlippmuschel, are often used to treat complaints of the musculoskeletal system, although these preparations are not approved…
View Post 4 min This content is machine translated Rheumatoid arthritis in the early stages Countermeasures in the early stages can prevent manifest rheumatoid arthritis It would be a dream: to identify patients in the early stages of rheumatoid arthritis (pre-RA) and to prevent the manifestation of the disease through efficient countermeasures. Is this also…
View Post 9 min This content is machine translated Cognitive disorders in multiple sclerosis Really “soft symptoms”? Cognitive impairment in MS should be taken very seriously. The everyday relevance of such symptoms is high. For example, patients’ ability to work depends crucially on their cognitive performance. Cognitive…
View Post 8 min This content is machine translated Psychiatric comorbidity in multiple sclerosis. Symptoms that should be taken seriously Psychiatric comorbidity in multiple sclerosis is common, with significant impact on quality of life. This should result in consequences for counseling and treatment. Interdisciplinary collaboration is required.
